Vice President, Clinical Development

Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases. The Kyverna therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Be at the forefront of cell therapy innovation by joining scientists, industry veterans and healthcare visionaries and help transform how autoimmune diseases are treated.

Kyverna is recruiting a VP, Clinical Development in its clinical development organization to help advance its mission to free patients from the siege of autoimmune disease. The ideal candidate will bring significant experience in advancing clinical development programs in neuroscience, rheumatology or cell therapy and provide strategic direction and oversight of overall clinical trial activities at Kyverna. The role will contribute to our goals of navigating what’s next in synthetic biology, immunology and cell engineering while living our core values: bring intellectual humility, elevate each other, and stay true to why.

Responsibilities

• Serve as the therapeutic area head and medical lead for neurology or rheumatology focused clinical programs, in partnership with internal and external cross-functional teams.
• Support the overall clinical development activities at Kyverna, providing strategic direction and oversight of clinical trial activities.
• Be responsible for advancing clinical programs and executing on clinical program deliverables.
• Development of clinical trial documents including protocols, ICFs, clinical development plans, and publications.
• Lead the development of clinical sections of regulatory documents including the IB, safety updates, clinical study reports, and responses to Health Authorities.
• Engage with external investigators, researchers, professional organizations, and corporate partners.
• Other duties as assigned.
  
  

Requirements

• MD (or ex-US equivalent), PhD, or MD-PhD degree, board certification in Neurology, Rheumatology, or Hematology-Oncology preferred
• 10 or more years of industry experience in clinical development involved in the design and execution of clinical trials.
• Specialty training in neurology, rheumatology, hematology-oncology and/or industry experience in clinical development of therapeutics in neuroscience or autoimmune diseases.
• Proven ability to interpret, discuss and present efficacy and safety data
• Working knowledge of GCP/ICH, clinical trial design, clinical development processes, and regulatory requirements.
• Strong ability to communicate and establish effective working relationship with investigators, collaborators, scientific advisors, CROs, and corporate partners.
  
  

The salary range for candidates residing in California for this position is $390,000 USD to $430,000 USD annually. This salary range is an estimate of what we reasonably expect to pay for this posted position, and the actual salary may vary based on various factors, including without limitation geographic location, individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock option plan.

Kyverna is an Equal Opportunity Employer and prohibits discrimination and harassment of any kind. Kyverna is committed to the principle of equal employment opportunity for all employees and does not discriminate on the basis of race, religion, color, sex, gender identify, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status or any other legally protected status. EOE/AA/Vets